FEBS Letters · 1992 · 99 citations · 16 references
Life SciencesPharmacologyPhysiologyCell SignalingMolecular PharmacologySignal TransductionMembrane ReceptorsReceptor BindingReceptor PharmacologyReceptor PhysiologyAntagonist ActivityEndothelin Receptor AntagonistsMembrane Receptor PharmacologyReceptorsSmooth Muscle ContractionVascular Smooth Muscle Pharmacology
In the inhibition of specific binding of [125I]endothelins (ETs) to membrane from various tissues of rats, guinea pigs, pigs and humans, [Cys11-Cys15]-ET-1(11-21), IRL 1038, has a much higher affinity for ETB receptors (Ki = 6-11 nM) than for ETA receptors (Ki = 0.4-0.7 microM). In contraction assays, with ET-3 as a stimulant, 3 microM IRL 1038 antagonized the ETB receptor-mediated contraction of guinea pig ileal and tracheal smooth muscle without any significant agonistic activity, but did not effect the ETA receptor-mediated contraction of rat aortic smooth muscle. IRL 1038 is therefore, considered to be the first antagonist selective to the ETB receptor.
16
A novel potent vasoconstrictor peptide produced by vascular endothelial cells
Masashi Yanagisawa, Hiroki Kurihara, Sadao Kimura et al. · Nature · 1988 · 10.8K citations · Full text
Akiko Inoue, Masashi Yanagisawa, Sadao Kimura et al. · Proceedings of the National Academy of Sciences · 1989 · 2.5K citations · Full text
Sarafotoxin, a Novel Vasoconstrictor Peptide: Phosphoinositide Hydrolysis in Rat Heart and Brain
Yoel Kloog, I. Ambar, Mordechai Sokolovsky et al. · Science · 1988 · 364 citations